Cryoport, Inc. provides cryogenic logistics solutions to the life sciences industry in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, a dry vapor cryogenic shipper that use liquid nitrogen contained inside a vacuum insulated vessel, which serves as a refrigerant to provide stable storage temperatures. It also provides Cryoport Express Standard Shippers, which are re-usable dry vapor liquid nitrogen storage containers for holding the biological material in the inner chamber; Cryoport Express High Volume Shippers, which use a dry vapor liquid nitrogen technology to maintain temperatures; and Cryoport Express CXVC1 Shipper can be used either as a dry vapor shipper or a liquid shipper. In addition, the company offers Cryoport Express CryoMax Shippers, a palletized dry shipper for lab moves and other high-volume transfers; Cryoport Express C3 Shippers designed to maintain a controlled temperature; Cryoport Express SmartPak II Condition Monitoring System to track the key aspects of each shipment; and Cryoport Express Analytics to track the time-based metrics for order processing time and on-time deliveries, as well as profiling shipping lanes to determine average transit times and predicting shipping exceptions based on historical metric. Further, it provides biological material holders that provide leak proof microbial barrier. Cryoport, Inc. was founded in 1999 and is headquartered in Irvine, California.
Industry, Sector and Symbol
Industry Freight transportation arrangement
Sub-IndustryN/A
SectorTransportation
SymbolNASDAQ:CYRX
CUSIPN/A
Phone949-470-2300
Debt
Debt-to-Equity RatioN/A
Current Ratio9.03
Quick Ratio8.98
Price-To-Earnings
Trailing P/E Ratio-43.68
Forward P/E Ratio-51.21
P/E GrowthN/A
Sales & Book Value
Annual Sales$11.95 million
Price / Sales34.19
Cash FlowN/A
Price / CashN/A
Book Value$0.70 per share
Price / Book21.21
Profitability
EPS (Most Recent Fiscal Year)($0.34)
Net Income$-7,890,000.00
Net Margins-66.29%
Return on Equity-48.12%
Return on Assets-42.77%
Miscellaneous
Employees57
Outstanding Shares27,510,000
CryoPort (NASDAQ:CYRX) Frequently Asked Questions
What is CryoPort's stock symbol?
CryoPort trades on the NASDAQ under the ticker symbol "CYRX."
How were CryoPort's earnings last quarter?
CryoPort Inc (NASDAQ:CYRX) announced its earnings results on Thursday, May, 3rd. The consumer goods maker reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.07) by $0.03. The consumer goods maker earned $4.02 million during the quarter, compared to analyst estimates of $3.84 million. CryoPort had a negative net margin of 66.29% and a negative return on equity of 48.12%. The company's revenue for the quarter was up 48.3% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.10) EPS. View CryoPort's Earnings History.
What price target have analysts set for CYRX?
4 equities research analysts have issued twelve-month price targets for CryoPort's stock. Their forecasts range from $11.00 to $12.50. On average, they anticipate CryoPort's share price to reach $11.6250 in the next year. View Analyst Ratings for CryoPort.
Who are some of CryoPort's key competitors?
Who are CryoPort's key executives?
CryoPort's management team includes the folowing people:
- Mr. Jerrell W. Shelton, Chairman, Pres & CEO (Age 73)
- Mr. Robert S. Stefanovich, CFO, Treasurer & Corp. Sec. (Age 53)
- Mr. Bret Bollinger, Chief Technology Officer (Age 51)
- Mr. Thomas J. Heinzen, VP of Corp. Devel. & Investor Relations
- Dr. Mark W. Sawicki Ph.D., Chief Commercial Officer
Has CryoPort been receiving favorable news coverage?
Media headlines about CYRX stock have been trending positive recently, Accern reports. Accern identifies positive and negative news coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. CryoPort earned a media sentiment score of 0.33 on Accern's scale. They also assigned news stories about the consumer goods maker an impact score of 47.51 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the near future.
Who are CryoPort's major shareholders?
CryoPort's stock is owned by a number of of retail and institutional investors. Top institutional investors include Millennium Management LLC (1.58%), Allianz Asset Management GmbH (1.38%), Allianz Asset Management GmbH (1.38%), BlackRock Inc. (1.04%), Needham Investment Management LLC (0.68%) and D.A. Davidson & CO. (0.57%). Company insiders that own CryoPort stock include Jerrell Shelton and Robert Stefanovich. View Institutional Ownership Trends for CryoPort.
Which institutional investors are selling CryoPort stock?
CYRX stock was sold by a variety of institutional investors in the last quarter, including Granite Investment Partners LLC, Barclays PLC, Fiera Capital Corp, Thompson Davis & CO. Inc., Allianz Asset Management GmbH and Allianz Asset Management GmbH. View Insider Buying and Selling for CryoPort.
Which institutional investors are buying CryoPort stock?
CYRX stock was bought by a variety of institutional investors in the last quarter, including Millennium Management LLC, BlackRock Inc., Needham Investment Management LLC, Tibra Equities Europe Ltd, D.A. Davidson & CO., Monarch Partners Asset Management LLC, Element Capital Management LLC and Northern Trust Corp. Company insiders that have bought CryoPort stock in the last two years include Jerrell Shelton and Robert Stefanovich. View Insider Buying and Selling for CryoPort.
How do I buy shares of CryoPort?
Shares of CYRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is CryoPort's stock price today?
One share of CYRX stock can currently be purchased for approximately $14.85.
How big of a company is CryoPort?
CryoPort has a market capitalization of $395.12 million and generates $11.95 million in revenue each year. The consumer goods maker earns $-7,890,000.00 in net income (profit) each year or ($0.34) on an earnings per share basis. CryoPort employs 57 workers across the globe.
How can I contact CryoPort?
CryoPort's mailing address is 17305 DAIMLER STREET, IRVINE CA, 92614. The consumer goods maker can be reached via phone at 949-470-2300 or via email at [email protected]
MarketBeat Community Rating for CryoPort (CYRX)
MarketBeat's community ratings are surveys of what our community members think about CryoPort and other stocks. Vote "Outperform" if you believe CYRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CYRX will underperform the S&P 500 over the long term. You may vote once every thirty days.
